PDS5B and acute myeloid leukemia: Similarly, patient-derived xenograft (PDX) mouse models demonstrated that the treatment with lipid nanoparticle (LNP)-formulated anti-HOXB-AS3 gapmers effectively downregulated HOXB-AS3 expression in human CD45-selected AML blasts isolated from the bone marrow of the treated mice.